Two decades after its creation, Cleveland Clinic’s rapid autopsy program for multiple sclerosis is yielding huge dividends by enabling a flurry of basic research as well as studies of novel MRI sequences.Read More
The first prospective randomized trial of scalp cooling shows that the therapy can significantly decrease chemotherapy-induced alopecia in breast cancer patients and is well tolerated.
Increased right ventricular pacing burden is the factor that best predicts pacing-induced cardiomyopathy in this population, a large new study shows. And CRT upgrade proves to be a reliable solution.
A series of events and meetings throughout his training led Nate Bergman, DO, MBA, to specialize in functional medicine. Now with Cleveland Clinic’s Center for Functional Medicine, Dr. Bergman has a special interest in how this practice can impact cognitive health.
The next decades will undoubtedly witness significant advances not only in gene transfer therapy, but also in stem cell and pharmacological therapies for patients with retinal dystrophies. Promising work and clinical trials are underway, and patients as well as physicians are looking forward to a brighter future.
New program for frontline nurses is promoting retention, driving ownership of outcomes, and encouraging further education. Going into its second year, the program shows success.
As reported at the 2016 San Antonio Breast Cancer Symposium, results from NSABP B-42 trial contradicted previous studies and showed no benefit with letrozole use beyond five years. But investigators say longer followup is needed.
At Cleveland Clinic, ethics consultations focus on helping patients, their families and healthcare professionals identify ethically supportable options.
Cleveland Clinic’s rehab hospitals are designed to maximize safe, appropriate transitions of care for geriatric patients.
Updates to Cleveland Clinic’s Nurse on Call program benefit patients, facilitate care coordination 24/7, and allow nurses to practice to the top of their licensure.